Effects of Concurrent and Consecutive Repetitive Transcranial Magnetic Stimulation (rTMS) and Cognitive Bias Modification (CBM)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorThe University of Hong Kong

About this trial

The goal of this study is to learn whether combining repetitive transcranial magnetic stimulation (rTMS) with a computerized behavioral intervention (imagery cognitive bias modification, CBM-I) reduces negative interpretation bias and mild-to-moderate depressive symptoms. The study will also examine neural changes in the dorsolateral prefrontal cortex (DLPFC) and whether timing of interventions affects outcomes.

The main questions it aims to answer are:

Does active TMS reduce negative interpretation bias and depressive symptoms more than sham TMS? Is delivering CBM-I concurrently with TMS more effective than delivering it consecutively (separate sessions) at reducing negative bias and depressive symptoms? Do combined rTMS + CBM-I approaches produce greater neural changes and improved cognitive control over self-referential interpretation than controls? Researchers will compare active TMS versus sham TMS, and concurrent versus consecutive delivery of CBM-I, to test effects on negative bias and depressive symptoms.

Participants will:

Receive either active rTMS or sham TMS targeting the DLPFC Complete imagery CBM-I sessions either concurrently with TMS or in separate (consecutive) sessions Undergo assessments of negative interpretation bias, depressive symptoms, and neural measures before and after the intervention

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18 years or above

Right-handed

Normal or corrected hearing and vision

Obtained primary education or above

Disqualifiers

History of severe physical disease, brain organic diseases, and neurological disorders (e.g., dementia, brain injury, stroke, epilepsy, Parkinson's disease)

History of substance use/ dependence/ withdrawal

Participants with intellectual disability based on IQ scores

Participants with contraindications for rTMS such as foreign metal bodies, implant devices (cochlear implants) or history (personal or family) of seizure

Trial design

Design model

Factorial

Treatments tested in this trial

  • TMS

    Device

    The rTMS group will receive 10 Hz stimulation to the left DLPFC at an intensity of 120% of the resting motor threshold of the right abductor pollicis brevis (APB) muscle with 4 sec trains and 11 sec intertrain intervals for 3000 pulses.Specifically in our study, we combine both intervention, but applying them concurrently and consecutively between groups.

  • Cognitive Bias Modification

    Behavioral

    Imagery CBM-I focuses on 2 cognitive aspects, mental imagery and interpretation. Participants will be presented with scenarios in which they have to imagine themselves to be in and practice constructing positive endings or interpretations for them.

  • Sham TMS

    Device

    The TMS coil will be rotated 90 degrees, and will not be delivering active stimulation to the participant. The intensity will be set to 30 and the TMS device will be active, generating enough sound effect but no real stimulation for sham control.

Treatment groups

180 Participants
are divided into 3 treatment groups
Group A: CC-R-CBMActive comparator 2 interventions
Group B: CC-S-CBMSham comparator 2 interventions
Group C: CS-R-CBMActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

Cognitive Bias

Measurement: Self-Referent Encoding Task Tool: PsychoPy Unit:Self-Referential Bias Index measured by positive and negative self-description affirmation

Time frame
"From enrollment to the end of treatment at 4 weeks"
2

Depressive Symptoms

Measurement: Beck's Depressive Inventory-II Tool: Qualtrics Questionnaire Unit:Beck's Depressive Inventory-II Index

Time frame
"From enrollment to the end of treatment at 4 weeks"
3

Resting State functional MRI

Measurement: resting-state functional MRI Image Tool: SIGNA Premier 3T wide-bore MRI scanner Unit: functional dicom images

Time frame
"From enrollment to the end of treatment at 4 weeks"

Secondary outcomes

1

Subjective Well Being

Measurement: Subjective Well-Being Scale Tool: Qualtrics Questionnaire Unit: Subjective Well-Being Index

Time frame
"From enrollment to the end of treatment at 4 weeks"
2

Sleep Quality

Measurement: Pittsburgh Sleep Quality Index (PSQI) Tool: Qualtrics Questionnaire Unit: Sleep Quality Index

Time frame
"From enrollment to the end of treatment at 4 weeks"
3

Anxiety Symptoms

Measurement: Beck Anxiety Inventory Task Tool: Qualtrics Questionnaire Unit: Anxiety Index

Time frame
"From enrollment to the end of treatment at 4 weeks"
4

Structural MRI

Measurement: T1 Structural MRI Brain Image Tool: SIGNA Premier 3T wide-bore MRI scanner Unit: structural dicom images

Time frame
"From enrollment to the end of treatment at 4 weeks"

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.